Interventional device closure has emerged as a less invasive alternative to surgery in the management of paravalvular leakage. However, this procedure involves various problems such as a high probability of residual leakage or hemolysis. Here, we report a case of residual paravalvular leakage despite two attempts at interventional closure in a patient with a history of four previous mitral valve replacements. The fifth operation for the primary repair of paravalvular leakage was performed successfully. Careful evaluation before the procedure and specially designed devices are essential for the interventional treatment of paravalvular leakage. Surgery can be performed adequately in the management of paravalvular leakage even in high-risk patients. 
CASE REPORT
A 71-year-old male was admitted due to progressive dyspnea associated with severe paraprosthetic mitral regurgitation.
The patient had previously undergone four mitral valve replacements (MVRs) before this admission. The first two operations had been performed in another hospital at the age of 38 years and 49 years, respectively. Two years before, he had been referred to our hospital for the management of paravalvular leakage 20 years after the second operation, at which he had undergone third MVR using a mechanical prosthesis leakage had progressively increased to a severe degree at the follow-up echocardiography, which was accompanied by the reappearance of severe heart failure symptoms. Furthermore, severe anemia in need of repetitive blood transfusion and development of renal insufficiency related to paraprosthetic hemolysis had gradually aggravated after re-admission. Therefore, the fifth operation was regarded as inevitable, and was finally undertaken 15 months after fourth MVR.
The surgical approach was attempted through a right thoracotomy; however, severe extensive periaortic adhesion precluded aortic clamping by this approach. Then, the incision was extended to an upper partial sternotomy, and the aortic cross-clamping site was finally secured ( Although cardiac function was sufficient for weaning from cardiopulmonary bypass (CPB), the actual weaning failed due to respiratory failure attributable to severe lung laceration and massive hemorrhage (Fig. 3) . Consequently, venovenous-type extracorporeal membrane oxygenation (ECMO) was applied; CPB weaning was then successfully achieved. The patient was successfully weaned off ECMO after 7 days of support.
Acute renal failure requiring renal replacement therapy was a complication faced during the ECMO support; this therapy was eventually discontinued after 24 days as the renal function recovered to normal levels. On the echocardiographic follow-ups performed immediately and at 1 month and 2 months after the surgery, neither residual paravalvular leakage nor an abnormal intracardiac flow was observed. The patient was discharged on postoperative day 61 with complete resolution of heart failure symptoms and hemolytic anemia.
DISCUSSION
Paraprosthetic regurgitation is a rare complication after heart valve surgery, but once significant leakage happens, it may result in serious complications such as congestive heart failure, hemolysis, and end-organ damage, ultimately hampering the patient outcomes. Repeated surgical correction has been the traditionally accepted treatment modality for paraprosthetic regurgitation, and the current practice guidelines also recommend surgery for the treatment of this complication for patients in whom it is feasible [1] . For high-risk patients, however, surgical correction may be associated with serious morbidity and mortality caused by the surgery itself [2] . In this regard, transcatheter device closure has recently emerged as a less-invasive alternative to surgical therapy [3, 4] .
After the first clinical experience of the transcatheter closure of paravalvular leakage was introduced in 1992 [5] , multiple case reports have confirmed its feasibility in selected patients. However, this procedure has been reported to be associated with various problems. For instance, residual leakage was observed in 10 out of 11 sites of device implantation in a series of 11 patients [6] . Furthermore, even when the degree of regurgitation is reduced, there are concerns regarding the significant hemolysis following the procedure [7] . 
